|
1
|
Riedemann NC, Guo RF and Ward PA: Novel
strategies for the treatment of sepsis. Nat Med. 9:517–524. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Phelps M, Coss C, Wang H and Cook M;
Reproducibility Project, ; Cancer Biology, ; Reproducibility
Project Cancer Biology, : Registered report: Coding-independent
regulation of the tumor suppressor PTEN by competing endogenous
mRNAs. Elife. 5(pii): e124702016.PubMed/NCBI
|
|
3
|
Li X, Zheng L, Zhang F, Hu J, Chou J, Liu
Y, Xing Y and Xi T: STARD13-correlated ceRNA network inhibits EMT
and metastasis of breast cancer. Oncotarget. 7:23197–23211.
2016.PubMed/NCBI
|
|
4
|
Tay Y, Karreth FA and Pandolfi PP:
Aberrant ceRNA activity drives lung cancer. Cell Res. 24:259–260.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang H, Wang F and Hu Y: STARD13 promotes
hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas.
Biotechnol Lett. 39:207–217. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y and Lin G: TP53INP1 3′-UTR
functions as a ceRNA in repressing the metastasis of glioma cells
by regulating miRNA activity. Biotechnol Lett. 38:1699–1707. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valdés-Ferrer SI, Papoin J, Dancho ME,
Olofsson P, Li J, Lipton JM, Avancena P, Yang H, Zou YR, Chavan SS,
et al: HMGB1 mediates anemia of inflammation in murine sepsis
survivors. Mol Med. Dec 29–2015.(Epub ahead of print). View Article : Google Scholar
|
|
8
|
Yang M, Cao L, Xie M, Yu Y, Kang R, Yang
L, Zhao M and Tang D: Chloroquine inhibits HMGB1 inflammatory
signaling and protects mice from lethal sepsis. Biochem Pharmacol.
86:410–418. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou W, Wang J, Li Z, Li J and Sang M:
MicroRNA-2055b inhibits HMGB1 expression in LPS-induced sepsis. Int
J Mol Med. 38:312–318. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang S, Li C, Wang W and Xing C: PBX3
promotes gastric cancer invasion and metastasis by inducing
epithelial-mesenchymal transition. Oncol Lett. 12:3485–3491. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ramberg H, Grytli HH, Nygård S, Wang W,
Ögren O, Zhao S, Løvf M, Katz B, Skotheim RI, Bjartell A, et al:
PBX3 is a putative biomarker of aggressive prostate cancer. Int J
Cancer. 139:1810–1820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han HB, Gu J, Ji DB, Li ZW, Zhang Y, Zhao
W, Wang LM and Zhang ZQ: PBX3 promotes migration and invasion of
colorectal cancer cells via activation of MAPK/ERK signaling
pathway. World J Gastroenterol. 20:18260–18270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Denzler R, Agarwal V, Stefano J, Bartel DP
and Stoffel M: Assessing the ceRNA hypothesis with quantitative
measurements of miRNA and target abundance. Mol Cell. 54:766–776.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Z, Huang A, Zhang A and Zhou C: HuR
promotes breast cancer cell proliferation and survival via binding
to CDK3 mRNA. Biomed Pharmacother. 91:788–795. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu CZ, Jiang C, Wu Q, Liu L, Yan X and Shi
R: A feed-forward regulatory loop between HuR and the long
noncoding RNA HOTAIR promotes head and neck squamous cell carcinoma
progression and metastasis. Cell Physiol Biochem. 40:1039–1051.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng L, Li X, Meng X, Chou J, Hu J, Zhang
F, Zhang Z, Xing Y, Liu Y and Xi T: Competing endogenous RNA
networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen
resistance in breast cancer. Mol Cell Endocrinol. 427:133–142.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tracey KJ, Beutler B, Lowry SF,
Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III,
Zentella A, Albert JD, et al: Shock and tissue injury induced by
recombinant human cachectin. Science. 234:470–474. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Bloom O, Zhang M, Vishnubhakat JM,
Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et
al: HMG-1 as a late mediator of endotoxin lethality in mice.
Science. 285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ishikawa M, Yamashita H, Oka N, Ueda T,
Kohama K, Nakao A and Kotani JL: Antithrombin III improved
neutrophil extracellular traps in lung after the onset of
endotoxemia. J Surg Res. 208:140–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li W, Zhu S, Zhang Y, Li J, Sama AE, Wang
P and Wang H: Use of animal model of sepsis to evaluate novel
herbal therapies. J Vis Exp. pii:39262012.
|
|
22
|
Zheng L, Li X, Gu Y, Ma Y and Xi T:
Pseudogene CYP4Z2P 3′UTR promotes angiogenesis in breast cancer.
Biochem Biophys Res Commun. 453:545–551. 2014. View Article : Google Scholar : PubMed/NCBI
|
